Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6272881 | 0.80 | ABL1 (0.38) | MEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL6267336 | 0.77 | ABL1 (0.48) | MEN1KMT2AMAPTALDH1A1TSHR | |
| SCHEMBL6270867 | 0.74 | SMN1; SMN2 (0.40) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL8333095 | 0.73 | TP53 (0.43) | MAPT | |
| SCHEMBL6184354 | 0.72 | AHR (0.40) | MEN1KMT2AMAPT | |
| SCHEMBL6273613 | 0.72 | ALOX5 (0.38) | MAPT | |
| SCHEMBL531848 | 0.72 | RXFP1 (0.65) | MEN1KMT2AMAPTALDH1A1GAA | |
| SCHEMBL8333850 | 0.70 | ALOX5 (0.62) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL6535504 | 0.70 | CASP3 (0.79) | EGFRCASP3CASP1CASP7 | |
| SCHEMBL6256089 | 0.69 | ABL1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1583967-A2 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | Bayer HealthCare AG (DE) | 2005-10-12 | — | — | EP | disclosed |
| WO-2005072741-A1 | ((11-OXO-10,11-DIHYDRODIBENZO [B, F] [1, 4] OXAZEPIN-1-YL)OXY) ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CARDIOVASCULAR PREPARATIONS USED TO TREAT ARTERIOLOSCLEROSIS | BAYER HEALTHCARE AG (DE) | 2005-08-11 | — | — | WO | disclosed |
| WO-2005072741-A1 | ((11-OXO-10,11-DIHYDRODIBENZO [B, F] [1, 4] OXAZEPIN-1-YL)OXY) ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CARDIOVASCULAR PREPARATIONS USED TO TREAT ARTERIOLOSCLEROSIS | BAYER HEALTHCARE AG (DE) | 2005-08-11 | — | — | WO | disclosed |
| WO-2004060860-A2 | METHOD FOR INHIBITING THE REPLICATION OF HERPES VIRUSES | BAYER HEALTHCARE AG (DE) | 2004-07-22 | — | — | WO | disclosed |